Sahar Bathaeian

Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity

A. Ghaemi, S. Miri, Elahe Abdolalipour, 2022, Frontiers in Immunology.

Clinical and Paraclinical Characteristics of COVID-19 patients: A systematic review and meta-analysis

R. Alizadeh-Navaei, D. Shamshirian, A. Shamshirian, 2020, medRxiv.